Roche says US approves Avastin drug to treat cervical cancer

Your Health Matters

The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in ShanghaiZURICH (Reuters) – Swiss drugmaker Roche said on Friday the U.S. Food and Drug Administration (FDA) had approved the use of its Avastin cancer drug in combination with chemotherapy to treat advanced cervical cancer. Avastin has now been approved to treat five distinct tumor types in the United States, Roche said. (Reporting by Alice Baghdjian)

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave